Compliance in Life Science
Klavs Esbjerg (Epista);Evi Larsen (Epista) and Einar Dyrhauge (AmCham)

Members of our life science stakeholders gathered at the AmCham Loft for a PowerBreakfast session on Compliance in the Life Sciences.

Growth, digitalization, patient-centricity: The Life Science industry is experiencing rapid change, and as the life sciences are conservative industries by nature – efficiencies in compliance are not inherent.

During the roundtable concrete ways to make compliance transparent throughout the entire organization were explored, and preparation measures were discussed on how to embrace impact of new regulations and technologies, keeping the organization in control.

Topic expert Klavs Esbjerg, CEO for Epista Life Science, shared details of Epista's 2017 report Compliance Maturity in the Danish Life Science. The roundtable discussion centered around key report conclusions on balancing best practice compliance, without overtaxing management and regulatory resources.

To download Klavs Esbjerg's presentation, click here

04 MSD07 Bayer06 DXC Technology03 Copenhagen Marriott05 Crowne Plaza02 Lockheed Martin08 Bristol-Myers Squibb09 Riskpoint10 Weibel11 Roche
AmCham Denmark · Dag Hammarskjölds Allé 13, 3 · 2100 Copenhagen Ø · Denmark · Phone (+45) 33 932 932 · E-mail: mail@amcham.dk · CVR: 24992314
Copyright© 2010 AmCham Denmark · All Rights Reserved